Obstetric outcomes after medroxyprogesterone acetate treatment for early stage endometrial cancer or atypical endometrial hyperplasia: a single hospital-based study.
Maki OishiYoshifumi KasugaYuka FukumaAsuka HamuroJunko TamaiYuya TanakaKeita HasegawaTakuma YoshimuraSatoru IkenoueDaigo OchiaiWataru YamagamiMamoru TanakaPublished in: International journal of clinical oncology (2023)
Pregnancy after MPA therapy is associated with a high risk of placenta accreta. In cases in which the frequency of D&C is high, placenta accreta should be considered.